SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 87.27 |
| Enterprise Value ($M) | 72.23 |
| Book Value ($M) | 32.32 |
| Book Value / Share | 0.22 |
| Price / Book | 2.70 |
| NCAV ($M) | 7.12 |
| NCAV / Share | 0.05 |
| Price / NCAV | 12.26 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.82 |
| Return on Assets (ROA) | -0.47 |
| Return on Equity (ROE) | -0.73 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 2.62 |
| Current Ratio | 2.97 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 35.22 |
| Assets | 60.42 |
| Liabilities | 28.10 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 16.89 |
| Operating Income | -38.14 |
| Net Income | -37.80 |
| Earnings Per Share Basic And Diluted | n/a |
| Earnings Per Share Diluted | n/a |
| Earnings Per Share Basic | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -21.68 |
| Cash from Investing | 0.15 |
| Cash from Financing | 36.83 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Adage Capital Management, L.P. | 5.37 | ||
| 13G | BlackRock, Inc. | 5.60 | 0.00 | |
| 13G/A | Millennium Management Llc | 4.00 | -22.99 | |
| 13G/A | Perceptive Advisors Llc | 3.80 | -28.93 | |
| 13G/A | Frost Phillip Md Et Al | 3.50 | 0.00 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A (Amendment No. 1) | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 1,027,678 | 2,309,957 | 44.49 | |
| 866,396 | 2,654,765 | 32.64 | |
| 894,214 | 2,886,214 | 30.98 | |
| 1,429,928 | 4,213,056 | 33.94 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| UNCY – Unicycive Therapeutics, Inc. | UPC – Universe Pharmaceuticals INC |
| UPXI – Upexi, Inc. | VINC – Vincerx Pharma, Inc. |
| VIRX – Viracta Therapeutics, Inc. |
Financial data and stock pages provided by
Fintel.io